BJCM
ABMD

Blue Jay Capital Management’s Abiomed Inc ABMD Stock Holding History

Blue Jay Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$7.94M Sell
55,387
-19,613
-26% -$2.64M 5.41% 9
2017
Q1 		$9.39M Buy
+75,000
New +$8.69M 4.62% 9
2016
Q3 		– Sell
-104,920
Closed -$11.5M – 22
2016
Q2 		$11.5M Sell
104,920
-18,670
-15% -$1.86M 7.53% 6
2016
Q1 		$11.7M Buy
+123,590
New +$10.4M 7.49% 6

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Blue Jay Capital Management's ABMD Position: Q2 2017 in Review

Blue Jay Capital Management reduced its Abiomed Inc (ABMD) stake by 26% in Q2 2017, selling an estimated $2.64M and leaving 55,387 shares worth $7.94M. The position accounts for 5.41% of the portfolio, ranked #9.

Blue Jay Capital Management first reported a position in ABMD in Q1 2016 and has held it in 4 quarters since. The position peaked at $11.7M in Q1 2016. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.

  • Blue Jay Capital Management held 55,387 shares of Abiomed Inc worth $7.94M as of Q2 2017.
  • Blue Jay Capital Management sold 19,613 Abiomed Inc shares in Q2 2017, an estimated $2.64M.
  • Abiomed Inc made up 5.41% of Blue Jay Capital Management's portfolio in Q2 2017, its #9 holding.
  • Blue Jay Capital Management first reported a position in Abiomed Inc in Q1 2016 and has held it in 4 quarters since.
  • Blue Jay Capital Management's Abiomed Inc position peaked at $11.7M in Q1 2016.
  • 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.